ArgusEye develops the Auga™ platform to provide real-time monitoring for bioprocesses in biopharma manufacturing. The company aims to enable more data-driven and continuous manufacturing workflows by delivering live process insights. With the newly announced €3.3M funding round, ArgusEye intends to accelerate technology development and expand commercially into key markets. Management said the capital will help scale the platform and broaden the customer base globally. The announcement did not disclose revenue, users, or a valuation.

Total raised

$7M

Funding rounds

2

Latest round

Equity

Latest activity

Apr 2026